TransAct Selling And Marketing Expenses vs Research Development Analysis

TACT Stock

USD 4.12 0.07 1.73%

TransAct Technologies financial indicator trend analysis is much more than just breaking down TransAct Technologies prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether TransAct Technologies is a good investment. Please check the relationship between TransAct Technologies Selling And Marketing Expenses and its Research Development accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TransAct Technologies Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Selling And Marketing Expenses vs Research Development

Selling And Marketing Expenses vs Research Development Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of TransAct Technologies Selling And Marketing Expenses account and Research Development. At this time, the significance of the direction appears to have strong relationship.

The correlation between TransAct Technologies' Selling And Marketing Expenses and Research Development is 0.68. Overlapping area represents the amount of variation of Selling And Marketing Expenses that can explain the historical movement of Research Development in the same time period over historical financial statements of TransAct Technologies Incorporated, assuming nothing else is changed. The correlation between historical values of TransAct Technologies' Selling And Marketing Expenses and Research Development is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Selling And Marketing Expenses of TransAct Technologies Incorporated are associated (or correlated) with its Research Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Research Development has no effect on the direction of Selling And Marketing Expenses i.e., TransAct Technologies' Selling And Marketing Expenses and Research Development go up and down completely randomly.

Correlation Coefficient

0.68

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Selling And Marketing Expenses

Research Development

Most indicators from TransAct Technologies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into TransAct Technologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TransAct Technologies Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

At this time, TransAct Technologies' Tax Provision is comparatively stable compared to the past year. Enterprise Value is likely to gain to about 199.9 M in 2024, whereas Selling General Administrative is likely to drop slightly above 10.1 M in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	15.2M	24.4M	38.4M	22.3M
Total Revenue	39.4M	58.1M	72.6M	59.6M

Gross Profit Total Revenue

TransAct Technologies fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Net Debt	Common Stock Total Equity	Common Stock
Total Assets		0.55	0.08	0.76	0.95	0.48	-0.02	0.53	0.73	0.82	0.4	0.73	0.46	0.01	0.39	0.48	0.1	0.52	0.82	0.37	0.97	0.45	-0.28	-0.63	0.8	0.82
Short Long Term Debt Total	0.55		-0.15	0.4	0.42	0.39	0.11	0.14	0.38	0.68	0.66	0.38	0.03	-0.44	0.71	0.4	0.61	0.19	0.58	0.33	0.44	0.45	-0.49	-0.07	0.51	0.59
Other Current Liab	0.08	-0.15		0.16	0.11	-0.17	-0.01	-0.05	0.03	-0.06	-0.33	0.03	0.08	0.05	-0.34	0.15	-0.26	0.03	0.03	0.13	0.13	0.4	-0.13	-0.11	0.19	0.1
Total Current Liabilities	0.76	0.4	0.16		0.56	0.45	-0.38	0.78	0.47	0.73	0.19	0.47	0.57	0.23	0.14	0.3	-0.1	0.62	0.92	0.45	0.7	0.58	-0.45	-0.29	0.75	0.75
Total Stockholder Equity	0.95	0.42	0.11	0.56		0.3	0.17	0.41	0.67	0.66	0.28	0.67	0.43	-0.05	0.27	0.52	0.04	0.37	0.62	0.25	0.97	0.32	-0.12	-0.68	0.7	0.69
Property Plant And Equipment Net	0.48	0.39	-0.17	0.45	0.3		-0.52	0.06	0.54	0.82	0.72	0.54	-0.19	0.3	0.77	-0.03	0.44	0.57	0.69	0.22	0.28	0.3	-0.22	-0.22	0.53	0.63
Retained Earnings	-0.02	0.11	-0.01	-0.38	0.17	-0.52		-0.09	-0.24	-0.29	-0.3	-0.24	0.16	-0.78	-0.11	0.23	0.06	-0.79	-0.34	-0.36	0.1	-0.35	0.08	0.04	-0.26	-0.25
Accounts Payable	0.53	0.14	-0.05	0.78	0.41	0.06	-0.09		0.19	0.37	-0.13	0.19	0.9	0.11	-0.15	0.06	-0.43	0.31	0.61	0.12	0.55	0.26	-0.14	-0.19	0.28	0.32
Cash	0.73	0.38	0.03	0.47	0.67	0.54	-0.24	0.19		0.69	0.62	1.0	0.02	-0.04	0.5	0.03	0.23	0.68	0.54	0.54	0.66	0.33	-0.45	-0.9	0.67	0.74
Non Current Assets Total	0.82	0.68	-0.06	0.73	0.66	0.82	-0.29	0.37	0.69		0.69	0.69	0.13	0.05	0.7	0.24	0.38	0.57	0.91	0.33	0.66	0.45	-0.47	-0.41	0.82	0.9
Non Currrent Assets Other	0.4	0.66	-0.33	0.19	0.28	0.72	-0.3	-0.13	0.62	0.69		0.62	-0.35	-0.02	0.89	-0.12	0.75	0.43	0.48	0.22	0.23	0.25	-0.33	-0.34	0.47	0.59
Cash And Short Term Investments	0.73	0.38	0.03	0.47	0.67	0.54	-0.24	0.19	1.0	0.69	0.62		0.02	-0.04	0.5	0.03	0.23	0.68	0.54	0.54	0.66	0.33	-0.45	-0.9	0.67	0.74
Net Receivables	0.46	0.03	0.08	0.57	0.43	-0.19	0.16	0.9	0.02	0.13	-0.35	0.02		0.04	-0.32	0.14	-0.56	0.1	0.38	-0.04	0.55	0.22	0.13	-0.13	0.07	0.08
Common Stock Shares Outstanding	0.01	-0.44	0.05	0.23	-0.05	0.3	-0.78	0.11	-0.04	0.05	-0.02	-0.04	0.04		-0.17	-0.08	-0.28	0.54	0.19	0.02	-0.01	0.12	0.43	0.04	0.1	0.01
Non Current Liabilities Total	0.39	0.71	-0.34	0.14	0.27	0.77	-0.11	-0.15	0.5	0.7	0.89	0.5	-0.32	-0.17		0.01	0.76	0.27	0.48	0.18	0.22	0.14	-0.23	-0.19	0.34	0.47
Inventory	0.48	0.4	0.15	0.3	0.52	-0.03	0.23	0.06	0.03	0.24	-0.12	0.03	0.14	-0.08	0.01		0.1	0.09	0.27	0.43	0.53	0.35	-0.04	0.05	0.44	0.28
Other Current Assets	0.1	0.61	-0.26	-0.1	0.04	0.44	0.06	-0.43	0.23	0.38	0.75	0.23	-0.56	-0.28	0.76	0.1		-0.03	0.2	0.12	-0.03	0.16	-0.35	0.04	0.3	0.35
Other Stockholder Equity	0.52	0.19	0.03	0.62	0.37	0.57	-0.79	0.31	0.68	0.57	0.43	0.68	0.1	0.54	0.27	0.09	-0.03		0.56	0.68	0.44	0.58	-0.2	-0.48	0.53	0.54
Total Liab	0.82	0.58	0.03	0.92	0.62	0.69	-0.34	0.61	0.54	0.91	0.48	0.54	0.38	0.19	0.48	0.27	0.2	0.56		0.33	0.7	0.49	-0.42	-0.29	0.81	0.84
Property Plant And Equipment Gross	0.37	0.33	0.13	0.45	0.25	0.22	-0.36	0.12	0.54	0.33	0.22	0.54	-0.04	0.02	0.18	0.43	0.12	0.68	0.33		0.35	0.55	-0.46	-0.32	0.48	0.39
Total Current Assets	0.97	0.44	0.13	0.7	0.97	0.28	0.1	0.55	0.66	0.66	0.23	0.66	0.55	-0.01	0.22	0.53	-0.03	0.44	0.7	0.35		0.41	-0.17	-0.65	0.71	0.69
Short Term Debt	0.45	0.45	0.4	0.58	0.32	0.3	-0.35	0.26	0.33	0.45	0.25	0.33	0.22	0.12	0.14	0.35	0.16	0.58	0.49	0.55	0.41		-0.39	-0.09	0.5	0.52
Intangible Assets	-0.28	-0.49	-0.13	-0.45	-0.12	-0.22	0.08	-0.14	-0.45	-0.47	-0.33	-0.45	0.13	0.43	-0.23	-0.04	-0.35	-0.2	-0.42	-0.46	-0.17	-0.39		0.23	-0.62	-0.67
Net Debt	-0.63	-0.07	-0.11	-0.29	-0.68	-0.22	0.04	-0.19	-0.9	-0.41	-0.34	-0.9	-0.13	0.04	-0.19	0.05	0.04	-0.48	-0.29	-0.32	-0.65	-0.09	0.23		-0.48	-0.52
Common Stock Total Equity	0.8	0.51	0.19	0.75	0.7	0.53	-0.26	0.28	0.67	0.82	0.47	0.67	0.07	0.1	0.34	0.44	0.3	0.53	0.81	0.48	0.71	0.5	-0.62	-0.48		0.96
Common Stock	0.82	0.59	0.1	0.75	0.69	0.63	-0.25	0.32	0.74	0.9	0.59	0.74	0.08	0.01	0.47	0.28	0.35	0.54	0.84	0.39	0.69	0.52	-0.67	-0.52	0.96

Click cells to compare fundamentals

TransAct Technologies Account Relationship Matchups

TransAct Technologies fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	36.1M	42.2M	50.9M	51.8M	54.2M	38.0M
Other Current Liab	3.0M	919K	3.1M	3.1M	4.7M	2.5M
Total Current Liabilities	7.6M	6.7M	9.8M	15.9M	13.6M	8.8M
Total Stockholder Equity	25.9M	30.2M	39.0M	33.9M	39.4M	26.3M
Property Plant And Equipment Net	5.1M	5.6M	5.2M	5.3M	4.0M	3.5M
Retained Earnings	25.3M	19.7M	15.6M	9.6M	14.4M	15.4M
Accounts Payable	3.0M	1.7M	4.3M	7.4M	4.4M	4.3M
Cash	4.2M	10.4M	19.5M	7.9M	12.3M	12.9M
Non Current Assets Total	11.1M	14.1M	13.8M	15.7M	13.2M	9.7M
Non Currrent Assets Other	44K	777K	400K	248K	163.0K	243.9K
Cash And Short Term Investments	4.2M	10.4M	19.5M	7.9M	12.3M	12.9M
Net Receivables	7.4M	3.5M	9.1M	15.4M	9.8M	9.4M
Common Stock Shares Outstanding	7.7M	7.8M	9.3M	9.9M	10.0M	7.4M
Liabilities And Stockholders Equity	36.1M	42.2M	50.9M	51.8M	54.2M	38.0M
Non Current Liabilities Total	2.5M	5.3M	2.2M	2.0M	1.1M	2.1M
Inventory	12.1M	11.3M	7.7M	12.0M	17.8M	11.2M
Other Current Assets	1.3M	3.1M	875K	724K	1.1M	994.2K
Other Stockholder Equity	494K	10.4M	23.1M	24.2M	24.9M	26.2M
Total Liab	10.1M	12.0M	12.0M	18.0M	14.8M	8.5M
Property Plant And Equipment Gross	5.1M	5.6M	5.2M	5.3M	22.7M	23.8M
Total Current Assets	25.0M	28.2M	37.1M	36.1M	41.0M	28.3M
Accumulated Other Comprehensive Income	(31K)	(38K)	143K	(79K)	(49K)	(51.5K)
Intangible Assets	817K	583K	397K	242K	88K	83.6K
Net Debt	(1.2M)	(4.5M)	(16.9M)	(3.1M)	(8.4M)	(8.0M)
Other Liab	385K	277K	373K	361K	324.9K	308.7K
Other Assets	2.6M	8.9M	5.5M	7.6M	1.0	0.95
Property Plant Equipment	2.2M	2.0M	5.2M	2.8M	2.5M	3.0M
Current Deferred Revenue	700K	504K	805K	1.3M	1.1M	543.2K
Net Tangible Assets	22.5M	27.0M	36.0M	31.0M	35.6M	28.8M
Retained Earnings Total Equity	27.5M	25.3M	19.7M	9.6M	8.7M	8.2M
Capital Surpluse	32.1M	32.6M	42.5M	56.3M	64.7M	36.0M
Non Current Liabilities Other	2.5M	3.1M	187K	218K	219K	208.1K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for TransAct Stock Analysis

When running TransAct Technologies' price analysis, check to measure TransAct Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransAct Technologies is operating at the current time. Most of TransAct Technologies' value examination focuses on studying past and present price action to predict the probability of TransAct Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransAct Technologies' price. Additionally, you may evaluate how the addition of TransAct Technologies to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC